Alderton W, Berghmans S, Butler P, Chassaing H, Fleming A, Golder Z, Richards F, Gardner I. 2010. Accumulation and metabolism of drugs and CYP probe substrates in zebrafish larvae. Xenobiotica 40: 547–557.
Amacher DE. 2002. A toxicologist's guide to biomarkers of hepatic response. Hum. Exp. Toxicol. 21: 253–262.
Amacher DE, Adler R, Herath A, Townsend RR. 2005. Use of proteomic methods to identify serum biomarkers associated with rat liver toxicity or hypertrophy. Clin. Chem. 51: 1796–1803.
Amaral JD, Xavier JM, Steer CJ, Rodrigues CM. 2010. The role of p53 in apoptosis. Discov. Med. 9: 145–152.
Berghmans S, Butler P, Goldsmith P, Waldron G, Gardner I, Golder Z, Richards FM, Kimber G, Roach A, Alderton W, Fleming A. 2008. Zebrafish based assays for the assessment of cardiac, visual and gut function – potential safety screens for early drug discovery. J. Pharmacol. Toxicol. Methods 58: 59–68.
Blieden M, Paramore LC, Shah D, Ben-Joseph R. 2014. A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States. Expert. Rev. Clin. Pharmacol. 7: 341–348.
Boess F, Kamber M, Romer S, Gasser R, Muller D, Albertini S, Suter L. 2003. Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. Toxicol. Sci. 73: 386–402.
Chng HT, Ho HK, Yap CW, Lam SH, Chan EC. 2012. An investigation of the bioactivation potential and metabolism profile of zebrafish versus human. J. Biomol. Screen. 17: 974–986.
Chu J, Sadler KC. 2009. New school in liver development: lessons from zebrafish. Hepatology 50: 1656–1663.
Cullen JM. 2005. Mechanistic classification of liver injury. Toxicol. Pathol. 33: 6–8.
de Jong G, van Dijk JP, van Eijk HG. 1990. The biology of transferrin. Clin. Chim. Acta 190: 1–46.
Driessen M, Kienhuis AS, Pennings JL, Pronk TE, van de Brandhof EJ, Roodbergen M, Spaink HP, van de Water B, van der Ven LT. 2013. Exploring the zebrafish embryo as an alternative model for the evaluation of liver toxicity by histopathology and expression profiling. Arch. Toxicol. 87: 807–823.
Driessen M, Kienhuis AS, Vitins AP, Pennings JL, Pronk TE, van den Brandhof EJ, Roodbergen M, van de Water B, van der Ven LT. 2014. Gene expression markers in the zebrafish embryo reflect a hepatotoxic response in animal models and humans 2. Toxicol. Lett. 230: 48–56.
Driessen M, Vitins AP, Pennings JL, Kienhuis AS, Water BV, van der Ven LT. 2015. A transcriptomics-based hepatotoxicity comparison between the zebrafish embryo and established human and rodent in vitro and in vivo models using cyclosporine A, amiodarone and acetaminophen 1. Toxicol. Lett. 232: 403–412.
Ekor M, Odewabi AO, Kale OE, Bamidele TO, Adesanoye OA, Farombi EO. 2013. Modulation of paracetamol-induced hepatotoxicity by phosphodiesterase isozyme inhibition in rats: a preliminary study. J. Basic Clin. Physiol. Pharmacol. 24: 73–79.
Elferink MG, Olinga P, Draaisma AL, Merema MT, Bauerschmidt S, Polman J, Schoonen WG, Groothuis GM. 2008. Microarray analysis in rat liver slices correctly predicts in vivo hepatotoxicity. Toxicol. Appl. Pharmacol. 229: 300–309.
EU. Commission implementing decision of 14 November 2012 establishing a common format for the submission of the information pursuant to Directive 2010/63/EU of the European Parliament and of the Council on the protection of animals used for scientific purposes.
Goetz AK, Dix DJ. 2009. Mode of action for reproductive and hepatic toxicity inferred from a genomic study of triazole antifungals. Toxicol. Sci. 110: 449–462.
Goetz AK, Bao W, Ren H, Schmid JE, Tully DB, Wood C, Rockett JC, Narotsky MG, Sun G, Lambert GR, Thai SF, Wolf DC, Nesnow S, Dix DJ. 2006. Gene expression profiling in the liver of CD-1 mice to characterize the hepatotoxicity of triazole fungicides. Toxicol. Appl. Pharmacol. 215: 274–284.
Goldstone JV, McArthur AG, Kubota A, Zanette J, Parente T, Jonsson ME, Nelson DR, Stegeman JJ. 2010. Identification and developmental expression of the full complement of Cytochrome P450 genes in Zebrafish. BMC Genomics 11: 643.
Guillouzo A, Corlu A, Aninat C, Glaise D, Morel F, Guguen-Guillouzo C. 2007. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem. Biol. Interact. 168: 66–73.
Gustafson AL, Stedman DB, Ball J, Hillegass JM, Flood A, Zhang CX, Panzica-Kelly J, Cao J, Coburn A, Enright BP, Tornesi MB, Hetheridge M, Augustine-Rauch KA. 2011. Inter-laboratory assessment of a harmonized zebrafish developmental toxicology assay – Progress report on phase I. Reprod. Toxicol. 33: 155–164.
He JH, Guo SY, Zhu F, Zhu JJ, Chen YX, Huang CJ, Gao JM, Dong QX, Xuan YX, Li CQ. 2013. A zebrafish phenotypic assay for assessing drug-induced hepatotoxicity. J. Pharmacol. Toxicol. Methods 67: 25–32.
Heni M, Wagner R, Ketterer C, Bohm A, Linder K, Machicao F, Machann J, Schick F, Hennige AM, Stefan N, Haring HU, Fritsche A, Staiger H. 2013. Genetic variation in NR1H4 encoding the bile acid receptor FXR determines fasting glucose and free fatty acid levels in humans. J. Clin. Endocrinol. Metab. 98: E1224–E1229.
Hertz R, Seckbach M, Zakin MM, Bar-Tana J. 1996. Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators. J. Biol. Chem. 271: 218–224.
Hill A, Mesens N, Steemans M, Xu JJ, Aleo MD. 2012. Comparisons between in vitro whole cell imaging and in vivo zebrafish-based approaches for identifying potential human hepatotoxicants earlier in pharmaceutical development. Drug Metab. Rev. 44: 127–140.
Howe K, Clark MD, Torroja CF, et al. 2013. The zebrafish reference genome sequence and its relationship to the human genome. Nature 496: 498–503.
Isogai S, Horiguchi M, Weinstein BM. 2001. The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. Dev. Biol. 230: 278–301.
Kienhuis AS, van de Poll MC, Wortelboer H, van Herwijnen M, Gottschalk R, Dejong CH, Boorsma A, Paules RS, Kleinjans JC, Stierum RH, van Delft JH. 2009. Parallelogram approach using rat-human in vitro and rat in vivo toxicogenomics predicts acetaminophen-induced hepatotoxicity in humans. Toxicol. Sci. 107: 544–552.
Koruk M, Taysi S, Savas MC, Yilmaz O, Akcay F, Karakok M. 2003. Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis. Turk. J. Gastroenterol. 14: 12–17.
Lake BG, Evans JG, Chapuis F, Walters DG, Price RJ. 2002. Studies on the disposition, metabolism and hepatotoxicity of coumarin in the rat and Syrian hamster. Food Chem. Toxicol. 40: 809–823.
Lam SH, Ung CY, Hlaing MM, Hu J, Li ZH, Mathavan S, Gong Z. 2013. Molecular insights into 4-nitrophenol-induced hepatotoxicity in zebrafish: Transcriptomic, histological and targeted gene expression analyses. Biochim. Biophys. Acta 1830: 4778–4789.
Lecluyse EL, Witek RP, Andersen ME, Powers MJ. 2012. Organotypic liver culture models: meeting current challenges in toxicity testing. Crit. Rev. Toxicol. 42: 501–548.
Lee WM. 2003. Drug-induced hepatotoxicity. N. Engl. J. Med. 349: 474–485.
Lee WM, Emerson DL, Young WO, Goldschmidt-Clermont PJ, Jollow DJ, Galbraith RM. 1987. Diminished serum Gc (vitamin D-binding protein) levels and increased Gc:G-actin complexes in a hamster model of fulminant hepatic necrosis. Hepatology 7: 825–830.
Mavropoulos A, Devos N, Biemar F, Zecchin E, Argenton F, Edlund H, Motte P, Martial JA, Peers B. 2005. sox4b is a key player of pancreatic alpha cell differentiation in zebrafish. Dev. Biol. 285: 211–223.
McGill MR, Sharpe MR, Williams CD, Taha M, Curry SC, Jaeschke H. 2012. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J. Clin. Invest. 122: 1574–1583.
Mennecozzi M, Landesmann B, Harris GA, Liska R, Whelan M. 2012. Hepatotoxicity screening taking a mode-of-action approach using HepaRG cells and HCA. ALTEX Proc. 1: 193–204.
Mesens N, Crawford AD, Menke A, Hung PD, Van Goethem F, Nuyts R, Hansen E, Wolterbeek A, Van Gompel GJ, De Witte P, Esguerra CV. 2015. Are zebrafish larvae suitable for assessing the hepatotoxicity potential of drug candidates? J. Appl. Toxicol. 35: 1017–1029.
Monbaliu D, de Vries B, Crabbe T, van Heurn E, Verwaest C, Roskams T, Fevery J, Pirenne J, Buurman WA. 2005. Liver fatty acid-binding protein: an early and sensitive plasma marker of hepatocellular damage and a reliable predictor of graft viability after liver transplantation from non-heart-beating donors. Transplant. Proc. 37: 413–416.
Mudumana SP, Wan H, Singh M, Korzh V, Gong Z. 2004. Expression analyses of zebrafish transferrin, ifabp, and elastaseB mRNAs as differentiation markers for the three major endodermal organs: liver, intestine, and exocrine pancreas. Dev. Dyn. 230: 165–173.
Nelson SD. 1990. Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin. Liver Dis. 10: 267–278.
Noel ES, Reis MD, Arain Z, Ober EA. 2010. Analysis of the Albumin/alpha-Fetoprotein/Afamin/Group specific component gene family in the context of zebrafish liver differentiation. Gene Expr. Patterns 10: 237–243.
O'Brien PJ, Irwin W, Diaz D, Howard-Cofield E, Krejsa CM, Slaughter MR, Gao B, Kaludercic N, Angeline A, Bernardi P, Brain P, Hougham C. 2006. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch. Toxicol. 80: 580–604.
Porter AG, Jänicke RU. 1999. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6: 99–104.
Ratra GS, Powell CJ, Park BK, Maggs JL, Cottrell S. 2000. Methapyrilene hepatotoxicity is associated with increased hepatic glutathione, the formation of glucuronide conjugates, and enterohepatic recirculation. Chem. Biol. Interact. 129: 279–295.
Schiodt FV, Ott P, Tygstrup N, Dahl B, Bondesen S. 2001. Temporal profile of total, bound, and free Gc-globulin after acetaminophen overdose. Liver Transpl. 7: 732–738.
Shi X, Gu A, Ji G, Li Y, Di J, Jin J, Hu F, Long Y, Xia Y, Lu C, Song L, Wang S, Wang X. 2011. Developmental toxicity of cypermethrin in embryo-larval stages of zebrafish. Chemosphere 85: 1010–1016.
Tseng HP, Hseu TH, Buhler DR, Wang WD, Hu CH. 2005. Constitutive and xenobiotics-induced expression of a novel CYP3A gene from zebrafish larva. Toxicol. Appl. Pharmacol. 205: 247–258.
Uehara T, Kiyosawa N, Shimizu T, Omura K, Hirode M, Imazawa T, Mizukawa Y, Ono A, Miyagishima T, Nagao T, Urushidani T. 2008. Species-specific differences in coumarin-induced hepatotoxicity as an example toxicogenomics-based approach to assessing risk of toxicity to humans. Hum. Exp. Toxicol. 27: 23–35.
van den Bulck K, Hill A, Mesens N, Diekman H, De SL, Lammens L. 2011. Zebrafish developmental toxicity assay: A fishy solution to reproductive toxicity screening, or just a red herring? Reprod. Toxicol. 32: 213–219.
Vliegenthart AD, Tucker CS, Del PJ, Dear JW. 2014. Zebrafish as model organisms for studying drug-induced liver injury 1. Br. J. Clin. Pharmacol. 78: 1217–1227.
Wiegand C, Pflugmacher S, Giese M, Frank H, Steinberg C. 2000. Uptake, toxicity, and effects on detoxication enzymes of atrazine and trifluoroacetate in embryos of zebrafish. Ecotoxicol. Environ. Saf. 45: 122–131.
Xu JJ, Henstock PV, Dunn MC, Smith AR, Chabot JR, de Graaf D. 2008. Cellular imaging predictions of clinical drug-induced liver injury. Toxicol. Sci. 105: 97–105.
Zakin MM. 1992. Regulation of transferrin gene expression. FASEB J. 6: 3253–3258.
